Potential risk factor of interleukin-10 gene polymorphism in acute myelogenous leukemia;Interlökin 10 gen polimorfizmi akut myeloid lösemi gelişiminde bir risk faktörü olabilir

THOD - Turk Hematoloji-Onkoloji Dergisi

Volumn 15, Issue 2, 2005, Pages 57-62

  Baştürk, Bilkay ^a   Evke, Elif ^b   Karakuş, Sema ^a   Tunali, Ahmet ^b  

^a BASKENT UNIVERSITY   (Turkey)

^b ULUDAG UNIVERSITY   (Turkey)

Author keywords

AML; Cytokine; Genotype; Polymorphism

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; LATENCY ASSOCIATED PEPTIDE; TRANSFORMING GROWTH FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION; RISK FACTOR; SINGLE STRAND CONFORMATION POLYMORPHISM; DNA POLYMORPHISM; GENETIC ANALYSIS;

EID: 21344433465     PISSN: 13018825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Graf M, Hecht K, Reif S, et al. Expression and prognostic value of hemopoetic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies. Eur J Haematol 72:89-106, 2004.
2. Guo H, Qiao Z, Zhu L, et al. Th1/Th2 cytokine profiles and their relationship to clinical features in patients following nonmyeloablative allogeneic stem cell transplantation. Am J Hematol 75:78-83, 2004.
3. Bidwell J, Keen L, Gallagher G. et al. Cytokine gene polymorphism in human disease. Genes and Immunity 1: 3-19, 1999.
4. Warzocha K, Ribeiro P, Bienvenu J. et al. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood 91: 3574-3581, 1998.
5. Beutler B, Cerami A. The Biology of cachectin/ TNF-α primary mediator of the host response. Annu Rev Immunol 7: 625-655, 1998.
6. Bidwell J.L, Wood N.A, Morse H.R, et al. Human cytokine gene nucleotide sequence aligments. Eur J Immunogenet 26:135-223, 1998.
7. Pravica V, Asderakis A, Perrey C. In vitro production of IFN-γ correlates with CA repeat polymorphism in IFN-γ gene. Eur J Immunogenet 26:1-3, 1999.
8. Turner DM, Williams DM, Sankaran D, et al. An investigation of polymorphism in the IL-10 gene promoter. Eur J Immunogenet 24:1-8, 1997.
9. Fishman D, Faulds G, Jeffery R, et al. Novel polymorphisms in the interleukin-6 gene: Their effect on IL-6 transcription, plasma IL-6 levels and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102: 1369-1376, 1998.
10. Awad RA, Webber S, Boyle G, et al. The effect of cytokine gene polymorphisms on pediatric heart allograft outcome. J Heart Lung Transplant 20:265, 2001.
11. Akalin E, Murphy B. Gene polymorphisms and transplantation. Current Oppinion Immunology 13:572-76, 2001.
12. Bidwell J, Keen L., Gallagher G, et al. Cytokine gene polymorphisim in human disease: on line data base. Genes and Immunity 1:3-19, 1999.
13. Hersh EM, Whitecar JP, Mc Credie K.B, et al. Chemotherapy, immunocompetence, immunosupression and prognosis in acute leukemia. N Engl J Med 285:1211-1220, 1971.
14. Buggins AG, Milojkovic D, Arno MJ, et al. Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-kappaB, c-Myc, and pRb pathways. J Immunol 15: 6021-30, 2001.
15. Kiertscher SM, Luo J, Dubinett M. Tumors promote altered maturation and early apoptosis of monocyte-derived dentritic cells. J Immnuol 164:1269-1275, 2000.
16. Chang HM, Paulson M, Holko M et al. Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity. Proc Natl Acad Sci USA. 29:9578-9583, 2004.
17. Shearer M, Taylor-Papadimitriou J. Regulation of cell growth by interferon. Cancer metastasis Rev 6:199-221, 1987.
18. O'Brien S, Kantarjien HM, Keating M. Association of granulocytosis with poor prognosis in patients with acut myelogenous leukaemia and translocation of chromosomes 8 and 21. J Clin Oncol 7:1081, 1989.
19. Krykowski E, Polkowska-Kuleska E, Robak T. Analysis of prognostic factors in acute leukemias in adults. Hematol Blood Transf 30:369, 1987.
20. Conti P, Kempuraj D, Kandere K, et al. IL-10 inflammatory/inhibitory cytokine, but not always. Immunology letters 86: 123-129, 2003.
21. Kube D, Rieth H, Eskdale J. et al. Stractural characterisation of the distal 5′ flanking region of the human interleukin-10 gene. Genes Immunity 2: 181, 2001.